pmc logo image
Logo of ajhgJournal URL: http://www.cell.com/AJHG/
Journal List > Am J Hum Genet > v.37(1); Jan 1985

Formats:
Am J Hum Genet. 1985 January; 37(1): 1–31.
PMCID: PMC1684548
Copyright notice
The natural history of homocystinuria due to cystathionine β-synthase deficiency
S. Harvey Mudd, Flemming Skovby, Harvey L. Levy, Karen D. Pettigrew, Bridget Wilcken, Reed E. Pyeritz, G. Andria, Godfried H. J. Boers, Irvin L. Bromberg, Roberto Cerone, Brian Fowler, H. Gröbe, Hildgund Schmidt, and Leslie Schweitzer
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
An international questionnaire survey has been conducted to define better the natural history of homocystinuria due to cystathionine β-synthase deficiency and permit evaluation of treatment. Data were compiled for 629 patients. Among patients not discovered by newborn screening, B6-responsive individuals on the average have significantly better mental capabilities (mean IQ, 79) than do B6-nonresponsive individuals (mean IQ, 57). Time-to-event curves are presented for the other major clinical abnormalities produced by this disease. Each occurred at significantly lower rates in untreated B6-responsive than in untreated B6-nonresponsive patients, as shown by the following examples: (1) dislocation of optic lenses (at age 10, chances of dislocation: 55% and 82%, respectively); (2) initial clinically detected thromboembolic events (at age 15, chances of having had such an event: 12% and 27%, respectively); (3) radiologic detection of spinal osteoporosis (at age 15, chances of such osteoporosis having been detected: 36% and 64%, respectively); and (4) mortality (at age 30, chances of not surviving: 4% and 23%, respectively). Methionine restriction initiated neonatally prevented mental retardation, retarded the rate of lens dislocation, and may have reduced the incidence of seizures. Pyridoxine treatment of late-detected B6-responsive patients retarded the rate of occurrence of initial thromboembolic events. Following 586 surgical procedures, 25 postoperative thromboembolic complications occurred, six of which were fatal. Reproductive histories were reported predominately for B6-responsive patients. Living offspring of either men or women patients had few abnormalities. The evidence is inconclusive whether untreated maternal cystathionine β-synthase deficiency leads to excessive fetal loss. Only 13% of patients detected in screening programs of newborns and classified as to B6-responsiveness were B6-responsive, compared to 47% among late-detected patients. Current screening programs that identify neonatal hypermethioninemia may be preferentially failing to detect B6-responsive patients.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 1
1
icon of scanned page 2
2
icon of scanned page 3
3
icon of scanned page 4
4
icon of scanned page 5
5
icon of scanned page 6
6
icon of scanned page 7
7
icon of scanned page 8
8
icon of scanned page 9
9
icon of scanned page 10
10
icon of scanned page 11
11
icon of scanned page 12
12
icon of scanned page 13
13
icon of scanned page 14
14
icon of scanned page 15
15
icon of scanned page 16
16
icon of scanned page 17
17
icon of scanned page 18
18
icon of scanned page 19
19
icon of scanned page 20
20
icon of scanned page 21
21
icon of scanned page 22
22
icon of scanned page 23
23
icon of scanned page 24
24
icon of scanned page 25
25
icon of scanned page 26
26
icon of scanned page 27
27
icon of scanned page 28
28
icon of scanned page 29
29
icon of scanned page 30
30
icon of scanned page 31
31
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • CARSON NA, NEILL DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child. 1962 Oct;37:505–513. [PubMed]
  • GERRITSEN T, VAUGHN JG, WAISMAN HA. The identification of homocystine in the urine. Biochem Biophys Res Commun. 1962 Dec 19;9:493–496. [PubMed]
  • MUDD SH, FINKELSTEIN JD, IRREVERRE F, LASTER L. HOMOCYSTINURIA: AN ENZYMATIC DEFECT. Science. 1964 Mar 27;143:1443–1445. [PubMed]
  • Schuh S, Rosenblatt DS, Cooper BA, Schroeder ML, Bishop AJ, Seargeant LE, Haworth JC. Homocystinuria and megaloblastic anemia responsive to vitamin B12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism. N Engl J Med. 1984 Mar 15;310(11):686–690. [PubMed]
  • Komrower GM, Lambert AM, Cusworth DC, Westall RG. Dietary treatment of homocystinuria. Arch Dis Child. 1966 Dec;41(220):666–671. [PubMed]
  • Perry TL, Hansen S, Love DL, Crawford LE, Tischler B. Treatment of homocystinuria with a low-methionine diet, supplemental cystine, and a methyl donor. Lancet. 1968 Aug 31;2(7566):474–478. [PubMed]
  • Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med. 1974 Sep 12;291(11):537–543. [PubMed]
  • Smolin LA, Benevenga NJ, Berlow S. The use of betaine for the treatment of homocystinuria. J Pediatr. 1981 Sep;99(3):467–472. [PubMed]
  • Wilcken DE, Wilcken B, Dudman NP, Tyrrell PA. Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med. 1983 Aug 25;309(8):448–453. [PubMed]
  • Mudd SH, Havlik R, Levy HL, McKusick VA, Feinleib M. A study of cardiovascular risk in heterozygotes for homocystinuria. Am J Hum Genet. 1981 Nov;33(6):883–893. [PubMed]
  • GEHAN EA. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed]
  • KOMROWER GM, WILSON VK. HOMOCYSTINURIA. Proc R Soc Med. 1963 Nov;56:996–997. [PubMed]
  • CARSON NA, DENT CE, FIELD CM, GAULL GE. HOMOCYSTINURIA: CLINICAL AND PATHOLOGICAL REVIEW OF TEN CASES. J Pediatr. 1965 Mar;66:565–583. [PubMed]
  • Brenton DP, Cusworth DC, Dent CE, Jones EE. Homocystinuria. Clinical and dietary studies. Q J Med. 1966 Jul;35(139):325–346. [PubMed]
  • Brett EM. Homocystinuria with epilepsy. Proc R Soc Med. 1966 Jun;59(6):484–487. [PubMed]
  • Dunn HG, Perry TL, Dolman CL. Homocystinuria. A recently discovered cause of mental defect and cerebrovascular thrombosis. Neurology. 1966 Apr;16(4):407–420. [PubMed]
  • Girard PF, Schott B, Bady B, Boucher M, David M. Observation d'homocystinurie familiale avec altérations carotidiennes et luxation du cristallin. Lyon Med. 1967 Dec 3;218(49):1369–1386. [PubMed]
  • Tancredi F, Fiore C, De Paola E, Auricchio S. Su di un caso di omocistinuria. Minerva Pediatr. 1967 Apr 7;19(14):642–646. [PubMed]
  • Carey MC, Donovan DE, FitzGerald O, McAuley FD. Homocystinuria. I. A clinical and pathological study of nine subjects in six families. Am J Med. 1968 Jul;45(1):7–25. [PubMed]
  • Gaudier B, François P, Biserte G, Dautrevaux M, Nuyts JP, Bombart E. L'homocystinurie (à propos de trois observations). Arch Fr Pediatr. 1968 May;25(5):541–560. [PubMed]
  • Hagberg B, Hambraeus L. Some aspects of the diagnosis and treatment of homocystinuria. Dev Med Child Neurol. 1968 Aug;10(4):479–484. [PubMed]
  • Price J, Vickers CF, Brooker BK. A case of homocystinuria with noteworthy dermatological features. J Ment Defic Res. 1968 Jun;12(2):111–118. [PubMed]
  • Verger P, Biserte G, Farriaux JP, Guillard JM, Roulaud F, Albert B. Deux nouveaux CAS D'homocystinurie. Lille Med. 1968 Apr;13(4):450–457. [PubMed]
  • Yoshida T, Tada K, Yokoyama Y, Arakawa T. Homocystinuria of vitamin B6 dependent type. Tohoku J Exp Med. 1968 Nov;96(3):235–242. [PubMed]
  • Barber GW, Spaeth GL. The successful treatment of homocystinuria with pyridoxine. J Pediatr. 1969 Sep;75(3):463–478. [PubMed]
  • Finkelstein JD, Fenichel GM, Reichmister J. Homocystinuria. Clin Proc Child Hosp Dist Columbia. 1969 Nov;25(10):291–307. [PubMed]
  • Gaudier B, Remy J, Nuyts JP, Caron-Poitreau C, Bombart E, Foissac-Gegoux MC. Etude radiologique des signes osseux de l'homocystinurie. (à propos de six observations). Arch Fr Pediatr. 1969;26(9):963–975. [PubMed]
  • Kaeser AC, Rodnight R, Ellis BA. Psychiatric and biochemical aspects of a case of homocystinuria. J Neurol Neurosurg Psychiatry. 1969 Apr;32(2):88–93. [PubMed]
  • Parkinson MS, Harper JR. Therapeutic problems of adolescent homocystinuria. Proc R Soc Med. 1969 Sep;62(9):909–910. [PubMed]
  • Garston JB, Gordon RR, Hart CT, Pollitt RJ. An unusual case of homocystinuria. Br J Ophthalmol. 1970 Apr;54(4):248–251. [PubMed]
  • Rahman M. Homocystinuria. Review of four cases. Br J Ophthalmol. 1971 May;55(5):338–342. [PubMed]
  • Morrow G, 3rd, Barness LA. Combined vitamin responsiveness in homocystinuria. J Pediatr. 1972 Nov;81(5):946–954. [PubMed]
  • Holmgren G. Urinary metabolic screening of mentally retarded patients from institutions in the northern part of Sweden. Hum Hered. 1973;23(6):548–560. [PubMed]
  • Hubert JP, Retif J, Brihaye J, Flament-Durand J. Etude anatomo-pathologique d'un cas d'homocystinurie. Pathol Eur. 1973;8(2):113–126. [PubMed]
  • Ritchie JW, Carson NA. Pregnancy and homocystinuria. J Obstet Gynaecol Br Commonw. 1973 Jul;80(7):664–669. [PubMed]
  • Hambraeus L, Holmgren G. Urinary metabolic screening in children with psycho-neurological diseases. Evaluation of different screening tests. Ups J Med Sci Suppl. 1974;15:1–23. [PubMed]
  • Holmgren G, Hambraeus L, Lestrup E, Tangen O. The effect of pyridoxine on platelet adhesiveness in homocystinuria. Neuropadiatrie. 1974 Nov;5(4):402–409. [PubMed]
  • Griffiths R, Tudball N. Studies on the use of skin fibroblasts for the measurement of cystathionine synthase activity with respect to homocystinuria. Clin Chim Acta. 1976 Nov 15;73(1):157–162. [PubMed]
  • Almgren B, Eriksson I, Hemmingsson A, Hillerdal G, Larsson E, Aberg H. Abdominal aortic aneurysm in homocystinuria. Acta Chir Scand. 1978;144(7-8):545–548. [PubMed]
  • Andlauer AC, David M, Feit JP, Macabeo V, Vibert J, Collombel C, Rolland MO, Jeune M. Homocystinurie et insuffisance respiratoire chronique. A propos d'une observation. Pediatrie. 1978 Oct–Nov;3(7):669–681. [PubMed]
  • Vandresse JH, de Saint Hubert E, Evrard P. Homocystinuria and carotid arteriography. Neuroradiology. 1978 Nov 24;17(1):57–58. [PubMed]
  • Regenbogen L, Ilie S, Elian I. Homocystinuria--a surgical and anaesthetic risk. Metab Pediatr Ophthalmol. 1980;4(4):209–211. [PubMed]
  • Meynadier J, Guilhou JJ, Thorel M, Barneon G. Homocystinurie. Etude histologique et ultrastructurale. A propos d'un cas. Dermatologica. 1981;163(1):34–41. [PubMed]
  • Autret E, Rivron J, Ramade J, Leroy J, Boulard P. Forme neurologique atypique avec chorée au cors d'une homocystinurie. Ann Pediatr (Paris). 1982 Mar;29(3):203–207. [PubMed]
  • Gröbe H. Homocystinuria (cystathionine synthase deficiency). Results of treatment in late-diagnosed patients. Eur J Pediatr. 1980 Dec;135(2):199–203. [PubMed]
  • CHOU SM, WAISMAN HA. SPONGY DEGENERATION OF THE CENTRAL NERVOUS SYSTEM: CASE OF HOMOCYSTINURIA. Arch Pathol. 1965 Apr;79:357–363. [PubMed]
  • Drayer JI, Cleophas AJ, Trijbels JM, Smals AG, Kloppenborg PW. Symptoms, diagnostic pitfalls, and treatment of homocystinuria in seven adult patients. Neth J Med. 1980;23(2):89–94. [PubMed]
  • Boers GH, Smals AG, Drayer JI, Trijbels FJ, Leermakers AI, Kloppenborg PW. Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients. Metabolism. 1983 Apr;32(4):390–397. [PubMed]
  • Brenton DP, Cusworth DC, Biddle SA, Garrod PJ, Lasley L. Pregnancy and homocystinuria. Ann Clin Biochem. 1977 May;14(3):161–162. [PubMed]
  • Wilcken B, Turner G. Homocystinuria in New South Wales. Arch Dis Child. 1978 Mar;53(3):242–245. [PubMed]
  • Skovby F, Kraus J, Redlich C, Rosenberg LE. Immunochemical studies on cultured fibroblasts from patients with homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1982 Jan;34(1):73–83. [PubMed]
  • Skovby F, Kraus JP, Rosenberg LE. Homocystinuria: biogenesis of cystathionine beta-synthase subunits in cultured fibroblasts and in an in vitro translation system programmed with fibroblast messenger RNA. Am J Hum Genet. 1984 Mar;36(2):452–459. [PubMed]
  • Crooke JW, Towers JF, Taylor WH. Management of patients with homocystinuria requiring surgery under general anaesthesia. A case report. Br J Anaesth. 1971 Jan;43(1):96–99. [PubMed]
  • Grover VK, Malhotra SK, Kaushik S. Anaesthesia and homocystinuria. Anaesthesia. 1979 Oct;34(9):913–914. [PubMed]
  • Frost PM. Anaesthesia and homocystinuria. Anaesthesia. 1980 Sep;35(9):918–919. [PubMed]
  • Parris WC, Quimby CW., Jr Anesthetic considerations for the patient with homocystinuria. Anesth Analg. 1982 Aug;61(8):708–710. [PubMed]
  • Schlesselman JJ. How does one assess the risk of abnormalities from human in vitro fertilization? Am J Obstet Gynecol. 1979 Sep 1;135(1):135–148. [PubMed]
  • Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med. 1980 Nov 20;303(21):1202–1208. [PubMed]
  • Hill-Zobel RL, Pyeritz RE, Scheffel U, Malpica O, Engin S, Camargo EE, Abbott M, Guilarte TR, Hill J, McIntyre PA, Murphy EA, Tsan MF. Kinetics and distribution of 111Indium-labeled platelets in patients with homocystinuria. N Engl J Med. 1982 Sep 23;307(13):781–786. [PubMed]
Articles from American Journal of Human Genetics are provided here courtesy of
American Society of Human Genetics

PubMed articles by these authors